LEADER 03457nam  22007095  450 
001 9910298311903321
005 20200704155137.0
010   $a1-4614-9108-8
024 7 $a10.1007/978-1-4614-9108-8
035   $a(CKB)2560000000148653
035   $a(EBL)1730863
035   $a(OCoLC)884587732
035   $a(SSID)ssj0001199642
035   $a(PQKBManifestationID)11692869
035   $a(PQKBTitleCode)TC0001199642
035   $a(PQKBWorkID)11204260
035   $a(PQKB)11725945
035   $a(MiAaPQ)EBC1730863
035   $a(DE-He213)978-1-4614-9108-8
035   $a(PPN)178316245
035   $a(EXLCZ)992560000000148653
100   $a20140419d2014      u|         0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 10$aPathogenesis of Leishmaniasis $eNew Developments in Research /$fedited by Abhay Satoskar, Ravi Durvasula
205   $a1st ed. 2014.
210  1$aNew York, NY :$cSpringer New York :$cImprint: Springer,$d2014.
215   $a1 online resource (98 p.)
300   $aDescription based upon print version of record.
311   $a1-4614-9107-X 
320   $aIncludes bibliographical references at the end of each chapters and index.
327   $aMechanisms of immunopathology of leishmaniasis -- Update on Leishmania mediators that promote immune evasion -- Paratransgenic Control of Leishmaniasis: New Developments -- Current status and future challenges for the development of Genetically Altered Live Attenuated Leishmania vaccines -- Reservoir control strategies for Leishmaniasis: past, present and future -- Treatment modalities for cutaneous and visceral leishmaniasis.  .
330   $a This book discusses recent developments in several laboratories studying leishmaniasis. Sequencing of the human genome, as well as of the leishmania genome, has led to significant advances in our understanding of host-immune responses against leishmania, and mechanisms of infection-induced pathology, which is responsible for morbidity and mortality. Pathogenesis of Leishmaniasis focuses on the latest basic research into leishmaniasis, but also addresses how advances in understanding can be applied to prevention, control and treatment of what the WHO has classified a neglected tropical disease.  .
606   $aParasitology
606   $aImmunology
606   $aMedical microbiology
606   $aVaccines
606   $aParasitology$3https://scigraph.springernature.com/ontologies/product-market-codes/B19002
606   $aImmunology$3https://scigraph.springernature.com/ontologies/product-market-codes/B14000
606   $aMedical Microbiology$3https://scigraph.springernature.com/ontologies/product-market-codes/B16003
606   $aVaccine$3https://scigraph.springernature.com/ontologies/product-market-codes/B16010
615  0$aParasitology.
615  0$aImmunology.
615  0$aMedical microbiology.
615  0$aVaccines.
615 14$aParasitology.
615 24$aImmunology.
615 24$aMedical Microbiology.
615 24$aVaccine.
676   $a610
676   $a615372
676   $a616.9041
676   $a616.9364
702   $aSatoskar$b Abhay$4edt$4http://id.loc.gov/vocabulary/relators/edt
702   $aDurvasula$b Ravi$4edt$4http://id.loc.gov/vocabulary/relators/edt
906   $aBOOK
912   $a9910298311903321
996   $aPathogenesis of Leishmaniasis$92499315
997   $aUNINA